Carl H. June

Carl H. June is a prominent American physician and researcher known for his groundbreaking work in the field of immunotherapy, particularly the development of CAR-T cell therapy. At 72 years old, he has pioneered a revolutionary approach that modifies T cells to attack cancer, specifically blood cancers. His research has opened pathways for treating various diseases, including autoimmune disorders and chronic infections, indicating a future where personalized genetic therapies could become commonplace in medicine. June's contributions have earned him significant recognition, including the Abarca Prize for his innovative strategies in cellular engineering.